News & Events

Press releases

Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication

READ MORE...

Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference

READ MORE...

Pneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024

READ MORE...

Pneumagen Announces Successful Clinical Proof of Concept for its Broad-Spectrum Antiviral Neumifil in Phase 2 Influenza Human Challenge Study

READ MORE...

Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil for the prevention & treatment of viral respiratory tract infections

READ MORE...

Pneumagen further strengthens IP protection for lead product Neumifil with granting of US composition of matter patent

READ MORE...

Pneumagen appoints James Noble, a highly experienced biotech leader, as Chairman of its Board of Directors

READ MORE...

Pneumagen Creates International Clinical Advisory Group of World Leading Respiratory and Infectious Disease Experts

READ MORE...

Pneumagen Announces First Patient Dosed in Phase 2 Proof of Concept Influenza Challenge Study Assessing Neumifil, an Intranasal Broad-Spectrum Antiviral

READ MORE...

Event information

Biotech Showcase and J.P. Morgan Healthcare Conference I January 13th – 16th 2025

READ MORE...

Jefferies London Healthcare Conference I 19th-21st November 2024

READ MORE...

BIO-Europe in Sweden I November 4th-6th 2024

READ MORE...

Bio€quity Europe in San Sebastian, Spain | May 12th – 14th 2024

READ MORE...

BioTrinity in London | April 23 – 24th 2024

READ MORE...

J.P. Morgan Healthcare Conference and Biotech Showcase I January 8th – 11th 2024

READ MORE...

Jefferies London Healthcare Conference I November 14th – 16th 2023

READ MORE...

BARDA Industry Day in Washington I November 13th-14th 2023

READ MORE...

BIO-Europe in Munich I November 6th-8th 2023

READ MORE...